(Q35110930)

6 August 2017

1 reference

title

Long QT syndrome caused by noncardiac drugs (English)

1 reference

Cardiology and cardiovascular medicine

6 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

25 December 2023

author name string

Sami Viskin

1

1 reference

6 August 2017

Dan Justo

2

1 reference

6 August 2017

Amir Halkin

3

1 reference

6 August 2017

David Zeltser

4

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12704598

25 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0033062003000094?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

https://api.elsevier.com/content/article/PII:S0033062003000094?httpAccept=text/plain

25 December 2023

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Progress in Cardiovascular Diseases

25 December 2023

published in

1 reference

6 August 2017

45

1 reference

6 August 2017

415-427

1 reference

6 August 2017

5

1 reference

Long QT syndromes and torsade de pointes

6 August 2017

1

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

The long QT syndromes: genetic basis and clinical implications

25 December 2023

2

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

25 December 2023

3

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death

25 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

25 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

25 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Thioridazine (mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker

25 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

25 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.

25 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes.

25 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns

25 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Cisapride-induced torsades de pointes

25 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model

25 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

25 December 2023

20

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

25 December 2023

21

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes

25 December 2023

24

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Pharmacogenetics and drug-induced arrhythmias

25 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

QT dispersion: problems of methodology and clinical significance.

25 December 2023

27

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Making QT correction simple is complicated

25 December 2023

28

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias

25 December 2023

29

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

25 December 2023

30

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence

25 December 2023

31

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Cisapride and fatal arrhythmia

25 December 2023

32

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Proarrhythmia associated with cisapride in children

25 December 2023

33

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Taking the "idio" out of "idiosyncratic": predicting torsades de pointes

25 December 2023

35

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Physiological and pathological responses of TU waves to class Ia antiarrhythmic drugs

25 December 2023

36

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies

25 December 2023

37

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes

25 December 2023

39

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

25 December 2023

Torsades de Pointes

40

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

25 December 2023

42

1 reference

https://api.crossref.org/works/10.1053/PCAD.2003.00101

25 December 2023

Identifiers

1 reference

6 August 2017

1 reference